Get the Stockscreener App
1.87
0.54%
-0.01
After Hours:
1.87
Hillevax Inc stock is traded at $1.87, with a volume of 254.92K.
It is down -0.54% in the last 24 hours and down -4.64% over the past month.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
See More
Previous Close:
$1.86
Open:
$1.86
24h Volume:
254.92K
Relative Volume:
1.13
Market Cap:
$93.76M
Revenue:
-
Net Income/Loss:
$-123.57M
P/E Ratio:
-0.6151
EPS:
-3.04
Net Cash Flow:
$-97.53M
1W Performance:
-0.54%
1M Performance:
-4.64%
6M Performance:
-4.15%
1Y Performance:
-84.75%
1-Day Range:
$1.835
$1.89
1-Week Range:
$1.82
$1.89
52-Week Range:
$1.34
$15.60
Hillevax Inc Stock (HLVX) Company Profile
Name
Hillevax Inc
Sector
Industry
Phone
(617) 213-5054
Address
321 HARRISON AVE, SUITE 500, BOSTON
Compare HLVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HLVX
Hillevax Inc
|
1.87 | 93.19M | 0 | -123.57M | -97.53M | -3.04 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.85 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 40.37M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.16 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
489.52 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
Hillevax Inc Stock (HLVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-09-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-09-24 | Downgrade | Stifel | Buy → Hold |
| Jul-08-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-23 | Initiated | H.C. Wainwright | Buy |
View All
Hillevax Inc Stock (HLVX) Latest News
HilleVax, Inc. (NASDAQ:HLVX) is largely controlled by institutional shareholders who own 51% of the company - Yahoo Finance
HilleVax, Inc. (NASDAQ:HLVX) Given Average Rating of “Hold” by Brokerages - Defense World
What is HC Wainwright’s Forecast for HilleVax Q2 Earnings? - Defense World
Voya Investment Management LLC Has $127,000 Stock Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Barclays PLC Raises Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
HilleVax Reports Improved Financial Performance - TipRanks
HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress - Bluefield Daily Telegraph
JPMorgan Chase & Co. Acquires 193,124 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Geode Capital Management LLC Decreases Stock Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Potential Price Increase for HilleVax Inc (HLVX) After Recent Insider Activity - knoxdaily.com
HilleVax, Inc. (NASDAQ:HLVX) Receives $3.00 Average PT from Analysts - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
HilleVax, Inc. (NASDAQ:HLVX) Shares Bought by Russell Investments Group Ltd. - Defense World
Bank of Montreal Can Acquires 11,459 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Is HilleVax Inc (HLVX) worth investing in despite its overvalued state? - uspostnews.com
ATTENTION HLVX SHAREHOLDERS: Investors who Lost Money on HilleVax, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation - ACCESS Newswire
HKVX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
HilleVax, Inc. (NASDAQ:HLVX) Receives $3.00 Consensus Price Target from Brokerages - Defense World
HilleVax (NASDAQ:HLVX) Given Neutral Rating at HC Wainwright - Defense World
Cautious Hold Rating on HilleVax Amid Norovirus Vaccine Development Setbacks - TipRanks
HilleVax Reports 2024 Financial Results Amid Strategic Exploration - MSN
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress - The Manila Times
HilleVax Inc. (HLVX) reports earnings - Quartz
HilleVax, Inc. SEC 10-K Report - TradingView
Shareholder Rights Advocates at Levi & Korsinsky Investigate HilleVax, Inc. (HLVX) Regarding Possible Securities Fraud Violations - ACCESS Newswire
HilleVax (HLVX) to Release Quarterly Earnings on Wednesday - Defense World
HILLEVAX Earnings Preview: Recent $HLVX Insider Trading, Hedge Fund Activity, and More - Nasdaq
HilleVax (NASDAQ:HLVX) & Omega Therapeutics (NASDAQ:OMGA) Critical Survey - Defense World
HKVX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm! - ACCESS Newswire
Hillevax CFO Shane Maltbie sells $15,116 in stock By Investing.com - Investing.com Nigeria
Stocks of HilleVax Inc (HLVX) are poised to climb above their peers - SETE News
Hillevax CEO Robert Hershberg sells $48,661 in stock - MSN
HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by SG Americas Securities LLC - Defense World
Hillevax CFO Shane Maltbie sells $15,116 in stock - MSN
HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Qiming U.S. Ventures Management LLC - MarketBeat
Top Executives Cash In on HilleVax Stock Sales - TipRanks
HilleVax Executives Sell Shares in February 2025 - TradingView
Vitro Diagnostics (OTCMKTS:VODG) vs. HilleVax (NASDAQ:HLVX) Financial Review - Defense World
HKVX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Stockholders to Contact the Firm! - ACCESS Newswire
HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by Barclays PLC - Defense World
Jane Street Group LLC Purchases 35,546 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Hillevax Inc Stock (HLVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hillevax Inc Stock (HLVX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT | See Remarks |
Feb 11 '25 |
Sale |
1.76 |
11,901 |
21,003 |
1,101,498 |
| Maltbie Shane | Chief Financial Officer |
Feb 11 '25 |
Sale |
1.76 |
4,345 |
7,659 |
79,887 |
| Maltbie Shane | Chief Financial Officer |
Feb 04 '25 |
Sale |
1.89 |
3,946 |
7,458 |
84,232 |
1.89%
3.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):